News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

Clinical performance evaluation of the LIVERFAStTM Tests to determine fibrosis staging, inflammatory activity and steatosis grading compared with Liver Biopsy in patients with metabolic factors and presumed Non- Alcoholic Fatty Liver Disease (NAFLD).

Study Status:

Closed for enrollment

Contact Information:

(956) 362-2356

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The primary objective of this study is to assess the clinical performance of LIVERFAStTM In Vitro Diagnostic (IVD) Tests (Fibrosis score, Activity score and Steatosis score) in NAFLD suspected patients for staging of fibrosis and for grading of inflammatory activity and steatosis, taking as reference the liver biopsy with histological classification of the elementary lesions determined according to SAF scores

Information: 

Principal Investigator
Fernando Membreno, MD
Co-PI
Frank Cimino
Sponsor
Fibronostics
Type of Trial
Interventional
© 2024 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram